Amgen to build biologics drug substance manufacturing facility in North Carolina
Amgen will build a new multi-product drug substance manufacturing facility in Holly Springs, North Carolina.
Amgen will build a new multi-product drug substance manufacturing facility in Holly Springs, North Carolina.
cphi north america 2021
Producers of CPhI North America 2021 offer a glimpse at programming, including sessions on COVID-19 challenges, supply chain issues, and more key topics.
cphi north america 2021
An industry study from the producer of CPhI North America shows the pandemic and other factors are contributing to a very dynamic pharmaceutical market.